AzTrials
AzTrials

Inflammatory ResponseNCT05039502

Releasing of Inflammatory Mediators During Retreatment of Root Canals

A study testing Protaper Universal Retreatment, Reciproc and XP-Endo finisher R in people with Inflammatory Response and Root Canal Infection, run by Bulent Ecevit University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Nonsurgical root canal retreatment may become essential when the initial endodontic treatment fails because of the persistent intracanal or extracanal infections.The aim of this thesis study is to evaluate the effect of ProTaper Universal Retreatment (PTUR), Reciproc blue and XP-endo Finisher R file systems, which are… Read more about this study

Who is it for?
Ages 18 to 68 yearsHealthy volunteers can take part
Conditions the study is for
Inflammatory Response, Root Canal Infection
What is being tested?
Protaper Universal Retreatment, Reciproc and XP-Endo finisher R
Could I receive a placebo?
No, everyone receives an active treatment
How many people
75 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Oct 2020to 1 Jun 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 68 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patients who had single root canal treated teeth with chronic periapical lesion

Who cannot join

  • Patients who are immunocompromised
  • Patients under antibiotic or analgesic medication

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Faculty of Dentistry of Bulent Ecevit University

    Zonguldak

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Different File Systems Used in Retreatment on the Release of Inflammatory Mediators

Nonsurgical root canal retreatment may become essential when the initial endodontic treatment fails because of the persistent intracanal or extracanal infections.The aim of this thesis study is to evaluate the effect of ProTaper Universal Retreatment (PTUR), Reciproc blue and XP-endo Finisher R file systems, which are used in the removal of root canal filling materials during retreatment with different motion kinetics on the release of Substance P, Calcitonin Gene-Related Peptide (CGRP), IL-6 and IL-10 inflammatory mediators in the periapical region

Read the detailed description

Seventy-five individuals with asymptomatic and chronic apical periodontitis teeth with retreatment indication were included in the study. Individuals were randomly divided into three groups according to the file system used to remove root canal filling materials (n = 25): ProTaper Universal Retreatment, Reciproc blue and XP-endo Finisher R.After the removal of the previous root canal filling materials, reshaping and disinfection of the root canals, periapical fluid samples were taken from the root tip of the teeth in all three groups. The amount of Substance P, CGRP, IL-6 and IL-10 mediators that cause pain, swelling and flare-up in periapical fluid samples were measured by ELISA test.

Being tested
Protaper Universal Retreatment, Reciproc, XP-Endo finisher R

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Protaper Universal RetreatmentOther

    D1-D2-D3 Retreatment files were used in 500 rpm and 3 Ncm with X-Smart endomotor

  • ReciprocOther

    R25 retratment files were used with X-Smart endomotor in reciprocal motion

  • XP-Endo finisher ROther

    XP-Endo finisher r file were used in 1000 rpm 1 Ncm with X-Smart endomotor

Study groups in NCT05039502
Study groupRoleWhat they receive
Retreatment system using in rotational motionExperimentalPrevious root canal filling materials were removed with D1-D2-D3 retreatment files with using an endodontic motor in rotational motion
Receives: Other: Protaper Universal Retreatment
Retreatment system using in reciprocal motionExperimentalPrevious root canal filling materials were removed with Reciproc 25 file with using an endodontic motor in reciprocal motion
Receives: Other: Reciproc
Retreatment system using in additional rotational motionExperimentalPrevious root canal filling materials were removed with XP-endo finisher r file with using an endodontic motor in rotational motion
Receives: Other: XP-Endo finisher R

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. change of inflammatory mediator level

    The samples were collected from periapical exudate at the end of the root canal retreatment procedure. The samples were analyzed with ELISA method and change of inflammatory mediator levels were evaluated in pg/ml.

    Measured: 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Sep 2021
  2. Study start1 Oct 2020
  3. Primary completion15 Mar 2021
  4. Study completion1 Jun 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
75 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05039502
Sponsor's protocol ID
2020-27194235-01
Status last verified
Sep 2021
First submitted
31 Aug 2021
Last updated
9 Sep 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Kasikci S, Turker SA, Guven B. Effect of different retreatment files using different kinematics on the release of inflammatory mediators in root canal retreatment of single-rooted teeth: a randomized clinical trial. Clin Oral Investig. 2023 Jun;27(6):3189-3196. doi: 10.1007/s00784-023-04930-6. Epub 2023 Mar 1.

    PubMed 36856848

Questions about this trial

What is this clinical trial studying?

A study testing Protaper Universal Retreatment, Reciproc and XP-Endo finisher R in people with Inflammatory Response and Root Canal Infection, run by Bulent Ecevit University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Sep 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

change of inflammatory mediator level (time frame: 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05039502, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Sep 2021; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in